SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-23-046380
Filing Date
2023-09-05
Accepted
2023-09-05 16:06:21
Documents
2
Period of Report
2023-09-01

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1595
2 EX-24 agle-ex24.htm EX-24 3570
  Complete submission text file 0000950170-23-046380.txt   6596
Mailing Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 17, SUITE 102B WALTHAM MA 02453 6176515940
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARCUTIS BIOTHERAPEUTICS, INC. 3027 TOWNSGATE ROAD, SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address
Burrows Scott L (Reporting) CIK: 0001853327 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37722 | Film No.: 231235756